Back to search

Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients

Data up to Jan 2025

Published1994
Citations139
References69

Total Citations Per Year

Abstract

References (69)

The Pathogenesis of Atherosclerosis — An Update

1986 • 4,951 citations

Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

1957 • 3,280 citations

HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY

1986 • 1,989 citations

Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis

1974 • 1,789 citations

Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction

1984 • 1,686 citations

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

1987 • 1,516 citations

Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in Uremia

1983 • 613 citations

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

1992 • 563 citations

Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

1988 • 561 citations

A Survey of Vascular Access for Haemodialysis in The Netherlands

1991 • 474 citations

ASSOCIATION BETWEEN SERUM ALBUMIN AND MORTALITY FROM CARDIOVASCULAR DISEASE, CANCER, AND OTHER CAUSES

1989 • 430 citations

Structure and function of thrombomodulin: a natural anticoagulant

1990 • 385 citations

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α

1990 • 346 citations

Heparin cofactor activity measured with an amidolytic method

1975 • 341 citations

Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.

1984 • 330 citations

Structure and function of thrombomodulin: a natural anticoagulant

1990 • 318 citations

Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's Disease

1981 • 314 citations

Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders [see comments]

1988 • 301 citations

Thrombomodulin is present in human plasma and urine.

1985 • 295 citations

Biosynthesis of von Willebrand protein by human megakaryocytes.

1985 • 271 citations

FEATURES OF ENDOTHELIAL DYSFUNCTION IN EARLY DIABETIC NEPHROPATHY

1989 • 251 citations

Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders [see comments]

1988 • 237 citations

Factor VIII on the Vascular Intima: Possible Importance in Haemostasis and Thrombosis

1973 • 219 citations

Tumor necrosis factor-alpha in human arterial wall with atherosclerosis

1991 • 215 citations

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.

1989 • 209 citations

Combined report on regular dialysis and transplantation in Europe, 3, 1972.

1973 • 188 citations

Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells

1990 • 182 citations

Effects of cytokines on vascular endothelium: Their role in vascular and immune injury

1989 • 161 citations

Purification of a Specific Placental Plasminogen Activator Inhibitor by Monoclonal Antibody and Its Complex Formation with Plasminogen Activator

1985 • 161 citations

Coagulation, fibrinolysis, and kallikrein systems in sepsis

1989 • 159 citations

Establishment of Enzyme Immunoassay of Human Thrombomodulin in Plasma and Urine Using Monoclonal Antibodies

1990 • 140 citations

Determination of plasminogen activator inhibitor in plasma using t-pa and a chromogenic single-point poly-D-lysine stimulated assay

1988 • 125 citations

A Six Year Prospective Study of Fibrinogen and Other Risk Factors Associated with Mortality in Stable Claudicants

1992 • 111 citations

PHYSIOLOGICAL MECHANISMS IN COAGULATION AND FIBRINOLYSIS

1977 • 111 citations

Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII

1978 • 109 citations

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure

1979 • 107 citations

Factor VIII related antigen in the assessment of vasculitis.

1987 • 102 citations

Sequential Changes in Factor VIII and Platelets Preceding Deep Vein Thrombosis in Patients with Spinal Cord Injury

1980 • 102 citations

Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells.

1988 • 96 citations

Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels.

1987 • 96 citations

Dinoflagellates near the Cretaceous Jurassic Boundary

1973 • 94 citations

On the Usefulness of Fibrinolysis Variables in the Characterization of a Risk Group for Myocardial Reinfarction

1987 • 88 citations

The Biosynthesis of Factor VIII

1979 • 86 citations

Transient disruptions of aortic endothelial cell plasma membranes.

1992 • 86 citations

Application of enzyme immunoassays to coagulation testing.

1984 • 78 citations

Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.

1984 • 77 citations

Antithrombin III and arterial disease

1991 • 76 citations

Combined report on regular dialysis and transplantation in Europe, VIII, 1977.

1978 • 75 citations

Heparin inactivation during blood storage : Its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole -C.T.A.D. mixture-

1983 • 73 citations

Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.

1992 • 59 citations

Impaired Fibrinolytic Capacity in Patients with Inflammatory Bowel Disease

1990 • 57 citations

Renal and Hepatic Handling of Endogenous Tissue-Type Plasminogen Activator (t-PA) and Its Inhibitor in Man

1988 • 56 citations

Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy

1990 • 55 citations

The Simultaneous Acute Release of Tissue-Type Plasminogen Activator and von Willebrand Factor in the Perfused Rat Hindleg Region

1990 • 46 citations

Activation of Platelets, Coagulation and Fibrinolysis in Patients on Long-Term Haemodialysis: Influence of Cuprophan and Polyacrylonitrile Membranes

1990 • 46 citations

Radioimmunoassay of urokinase for quantification of plasminogen activators released in ovarian tumour cultures

1981 • 44 citations

Biological Control of Tissue Plasminogen Activator-Mediated Fibrinolysis

1988 • 44 citations

Single-Chain Urokinase-Type Plasminogen Activator: Mechanism of Action and Thrombolytic Properties

1987 • 40 citations

DDAVP Induces Systemic Release of Urokinase-Type Plasminogen Activator

1989 • 38 citations

Enhanced Coagulation-Fibrinolysis in Patients on Regular Hemodialysis Treatment

1991 • 37 citations

Gamma-interferon modulates von Willebrand factor release by cultured human endothelial cells

1990 • 33 citations

Role of von Willebrand Factor in the Vessel Wall

1987 • 30 citations

Comparison of specificities of antigen assays for plasminogen activator inhibitor 1(PAI-1)

1990 • 17 citations

Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance hemodialysis.

1984 • 14 citations

Characterization of Monoclonal Antibodies to Human Tissue-Type Plasminogen Activator: Catalytic Inhibition and One-Two Chain Discriminatory Reactivities

1989 • 9 citations

Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis.

1989 • 6 citations

[Soluble thrombomodulin: a specific parameter of endothelial injury].

1991 • 6 citations

Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytes

1993 • 4 citations

Thrombomodulin.

1989 • 1 citations

Cited By (0)

Loading...